Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase the risk of adverse drug reactions (ADR), notably hematological disorders (anemia, thromb...
Saved in:
Main Authors: | Hélène Thirot (Author), Caroline Briquet (Author), Frédéric Frippiat (Author), Frédérique Jacobs (Author), Xavier Holemans (Author), Séverine Henrard (Author), Paul M. Tulkens (Author), Anne Spinewine (Author), Françoise Van Bambeke (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
by: Hélène Thirot, et al.
Published: (2024) -
Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data
by: Catherine Pétein, et al.
Published: (2021) -
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis
by: Chandrasekaran Padmapriyadarsini, et al.
Published: (2023) -
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology"
by: Françoise Van Bambeke, et al.
Published: (2023) -
Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database
by: Bogdan Ioan Vintila, et al.
Published: (2023)